Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Smith & Nephew, Inc. REDAPT Augments

K-Number: K171073 · 2017-11-21

Decision Date2017-11-21
Product CodeLPH
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

Smith & Nephew, Inc. REDAPT Augments is a medical device manufactured by Smith & Nephew, Inc.. It received FDA 510(k) clearance on 2017-11-21 under approval number K171073. The device is classified under product code LPH. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Smith & Nephew, Inc. REDAPT Augments?

Smith & Nephew, Inc. REDAPT Augments is a medical device that received FDA 510(k) clearance on 2017-11-21. It is manufactured by Smith & Nephew, Inc.. The 510(k) number is K171073.

When was Smith & Nephew, Inc. REDAPT Augments approved by the FDA?

Smith & Nephew, Inc. REDAPT Augments received FDA 510(k) clearance on 2017-11-21, under approval number K171073.

What company makes Smith & Nephew, Inc. REDAPT Augments?

Smith & Nephew, Inc. REDAPT Augments is manufactured by Smith & Nephew, Inc..

What is the FDA product code for Smith & Nephew, Inc. REDAPT Augments?

The FDA product code for Smith & Nephew, Inc. REDAPT Augments is LPH.

Related Clinical Trials

Other Devices by Smith & Nephew, Inc.

View all 107 devices →

Related Devices (Code: LPH)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.